1. Canada Stocks

  2. •

    Consumer Cyclical

  3. •

    Personal Products & Services
KDA Group Inc.

KDA Group Inc.

KDA.V
KDA Group Inc.CA flagToronto Stock Exchange Ventures
0.06
CAD
- -
- -
14.12MMarket Cap
KDA Group Inc.
KDA.V
(Toronto Stock Exchange Ventures)

Recent

price

0.06

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
0.59
0.42
0.31
0.73
0.48
0.31
0.21
0.19
- -
- -
- -
- -
- -
Revenue per Share
-0.04
-0.02
-0.01
-0.01
0.11
-0.1
-0.06
-0.2
-0.12
-0.12
-0.04
- -
-0.03
0.11
-0.04
-0.04
-0.03
Basic EPS, GAAP
-0.01
- -
- -
- -
- -
-0.05
-0.03
-0.03
0.01
-0.04
-0.01
- -
-0.01
-0.02
-0.02
-0.02
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.01
-0.01
-0.01
-0.02
-0.22
0.01
-0.03
0.02
-0.08
-0.07
-0.03
0.03
- -
0.1
0.07
0.06
0.03
Book Value per Share
0.01
-0.01
-0.01
-0.02
-0.22
-0.16
-0.2
-0.42
-0.3
-0.17
-0.09
-0.07
-0.11
0.03
0.01
0.01
-0.01
Tangible Book Value per Share
5
5
5
5
6
13
25
41
43
74
111
126
148
149
169
183
193
Basic Weighted Avg Shares
- -
- -
- -
- -
4
5
8
30
20
23
23
24
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
5.52
-1.91
1.66
6.69
-1,804.43
-2,053.85
-3,142.31
-5,407.78
-1,620.8
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
- -
1
- -
3
3
3
Depreciation Expense
- -
- -
- -
- -
1
-1
-1
-8
-5
-9
-4
1
-5
16
-7
-8
-6
Net Income, GAAP
- -
- -
- -
- -
23.22
- -
- -
- -
- -
- -
- -
- -
- -
74.99
- -
- -
- -
Effective Tax Rate (%)
-9,207.92
-423.51
5,619.42
3,537.89
18.04
-23.49
-19.07
-26.93
-25.56
-36.88
-18.83
2.3
-2,203.03
10,015.99
-4,686.11
-4,866.3
-1,437.21
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-12
-10
-4
-2
-15
3
1
- -
-2
Working Capital
- -
- -
- -
- -
- -
3
1
1
2
- -
1
6
6
1
1
- -
- -
LT Debt
- -
- -
- -
- -
-1
- -
-1
1
-3
-7
-4
4
- -
17
12
9
6
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-4.77
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
-89.69
- -
- -
- -
- -
- -
- -
- -
- -
96.68
- -
- -
- -
Return on Capital (%)
-125.65
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-47.64
-68.9
-75.24
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Oct'26
Jan'26
Apr'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
194
200
235
Market Capitalization
50
42
28

Working Capital

FRC

•

in mil. unless spec.
Oct'26
Jan'26
Apr'26
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
1
1
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-969.56%
-1,719.63%
-21.41%
Free Cash Flow
-191.78%
-80.9%
-6.6%
Net Income, GAAP
-116.58%
-321.11%
16.52%
Sales/Revenue/Turnover
19.76%
-22.24%
12.2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-0.01
-0.01
- -
-0.04
2025
-0.01
-0.01
-0.01
- -
-0.04
2026
-0.01
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Central Parking Finance Trust PFD TR CV SECS (CRLKP)
Carriage Services, Inc. (CSV)
Shukra Bullions Limited (SKRABUL.BO)
MPM Corpóreos S.A. (ESPA3.SA)
Kandal M Venture Limited (FMFC)
Convano Inc. (6574.T)
Business
KDA Group Inc. develops and markets healthcare technology and operational-efficiency solutions for general and specialized healthcare markets in Canada and internationally. The Company’s pharmaceutical technology portfolio comprises KRx, an electronic-prescribing platform that streamlines and secures prescription workflows for medical clinics; Adherize+, an intelligent, secure patient-engagement and medication-adherence platform that automates patient follow-up and delivers tailored interventions; Medherize, an Adherize+ module for patients receiving complex therapies, including oral oncology treatments, that supports therapeutic monitoring and clinical intervention; and CareMedic, an integrated digital-health-record and care-coordination platform that centralizes patient medical histories, laboratory results, allergies and medication schedules and supports secure communication among healthcare providers and patients. KDA also develops digital-health, artificial-intelligence and medical-education solutions designed to support healthcare professionals, pharmaceutical-sector stakeholders and patients. Founded in 2008, the Company is headquartered in Thetford Mines, Québec, Canada, and operates through its Pharmaceutical Technology segment and subsidiaries, including Groupe Technologique KDA Inc. Formerly known as AlliancePharma Inc., KDA adopted its current name in February 2017. Recent developments include the April 2025 certification of Adherize+ as a Santé Québec technological product or service; a December 2025 partnership and collaboration agreement with CHU de Québec–Université Laval to deploy the Medherize platform at Hôpital du Saint-Sacrement; and the March 2026 completion of KDA’s acquisition of the remaining 20% minority interest in Groupe Technologique KDA Inc. from ERxpert Inc., making the subsidiary wholly owned in exchange for 35,000,000 KDA common shares.